We are live on ! Find out more
GS

Gagnon Securities Portfolio holdings

AUM $519M
1-Year Est. Return 44.91%
This Fund
S&P 500
This Quarter Est. Return
+14.28%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$417M
AUM Growth
+$17.5M
Cap. Flow
-$15.6M
Cap. Flow %
-3.76%
Top 10 Hldgs %
48.3%
Holding
110
New
13
Increased
27
Reduced
59
Closed
8

Top Buys

Rank Stock Value
1
AMRC icon
Ameresco
AMRC
+$2.76M
2
DV icon
DoubleVerify
DV
+$2.65M
3
VERX icon
Vertex
VERX
+$2.54M
4
ICUI icon
ICU Medical
ICUI
+$822K
5
GNL icon
Global Net Lease
GNL
+$567K

Sector Composition

Rank Sector Weight
1 Healthcare 34.58%
2 Technology 23.52%
3 Industrials 13.73%
4 Consumer Discretionary 11.23%
5 Energy 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXAS
26
DELISTED
Exact Sciences
EXAS
$5.14M 1.23%
69,430
+2,909
+4% +$191K
GNRC icon
27
Generac Holdings
GNRC
$12.7B
$4.91M 1.18%
37,987
+569
+2% +$62.4K
CTRE icon
28
CareTrust REIT
CTRE
$9.72B
$4.12M 0.99%
184,307
-561
-0.3% -$12.4K
PRLB icon
29
Protolabs
PRLB
$2.14B
$3.59M 0.86%
92,026
+1,736
+2% +$56.2K
CNF
30
CNFinance Holdings
CNF
$36.2M
$3.54M 0.85%
159,342
-2,345
-1% -$59.9K
AKAM icon
31
Akamai
AKAM
$17B
$3.53M 0.85%
29,868
-178
-0.6% -$19.8K
KLTR icon
32
Kaltura
KLTR
$268M
$3.39M 0.81%
1,737,506
-14,973
-0.9% -$26.4K
DV icon
33
DoubleVerify
DV
$1.81B
$3.13M 0.75%
+84,973
New +$2.65M
VERX icon
34
Vertex
VERX
$1.9B
$2.67M 0.64%
+99,030
New +$2.54M
PSIX
35
Power Solutions International
PSIX
$762M
$2.63M 0.63%
1,282,137
-14,222
-1% -$29.2K
PNTG icon
36
Pennant Group
PNTG
$1.35B
$2.62M 0.63%
188,425
-946
-0.5% -$11.8K
ICUI icon
37
ICU Medical
ICUI
$4.17B
$2.23M 0.54%
22,353
+8,411
+60% +$822K
SLGC
38
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$2.04M 0.49%
805,224
-1,920
-0.2% -$4.47K
GNTX icon
39
Gentex
GNTX
$5B
$1.95M 0.47%
59,569
+46
+0.1% +$1.42K
MCHP icon
40
Microchip Technology
MCHP
$42.3B
$1.9M 0.46%
21,056
-38
-0.2% -$3.09K
TPR icon
41
Tapestry
TPR
$32.5B
$1.89M 0.45%
51,234
+167
+0.3% +$5.14K
SLG icon
42
SL Green Realty
SLG
$3.88B
$1.74M 0.42%
38,488
-13,949
-27% -$514K
PTEN icon
43
Patterson-UTI
PTEN
$3.87B
$1.68M 0.4%
155,726
+1,584
+1% +$19.3K
ALT icon
44
Altimmune
ALT
$580M
$1.25M 0.3%
111,342
-180
-0.2% -$752
DVN icon
45
Devon Energy
DVN
$49.7B
$1.13M 0.27%
24,978
-47
-0.2% -$2.15K
GNL icon
46
Global Net Lease
GNL
$1.91B
$1.04M 0.25%
104,911
+64,830
+162% +$567K
PFE icon
47
Pfizer
PFE
$148B
$1.03M 0.25%
35,922
+4,918
+16% +$149K
MRVL icon
48
Marvell Technology
MRVL
$191B
$1.03M 0.25%
17,002
-112
-0.7% -$6.05K
WGS icon
49
GeneDx Holdings
WGS
$2.03B
$961K 0.23%
349,278
-26,805
-7% -$62.3K
XOM icon
50
ExxonMobil
XOM
$637B
$932K 0.22%
9,321
-1,114
-11% -$117K

Similar funds

Gagnon Securities's Q4 2023 Portfolio in Review

As of Q4 2023, Gagnon Securities held 110 positions worth $417M, up 4.4% from $399M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Gagnon Securities withdrew a net $15.6M in Q4 2023, closing 8 positions and reducing 59 holdings. Its most notable exit was Miromatrix Medical Inc. Common Stock, an estimated $1.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

Against the trend, Gagnon Securities opened a new position in DoubleVerify worth $3.13M.

  • Gagnon Securities's largest Q4 2023 buy was DoubleVerify: 84,973 shares worth $3.13M.
  • Gagnon Securities added most to Ameresco in Q4 2023, an estimated $2.76M increase.
  • Gagnon Securities's biggest Q4 2023 reduction was Yext, cutting an estimated $6.18M.
  • Gagnon Securities fully exited Miromatrix Medical Inc. Common Stock in Q4 2023, selling an estimated $1.91M.
  • Gagnon Securities's ten largest holdings make up 48% of its $417M portfolio in Q4 2023.
  • Gagnon Securities opened 13 new positions and closed 8 in Q4 2023.
  • Gagnon Securities's portfolio value rose 4.4% quarter-over-quarter to $417M.

Based on Gagnon Securities's 13F filing for Q4 2023, filed 14 Feb 2024.